Cite
HARVARD Citation
Mateo, J. et al. (2018). A framework to rank genomic alterations as targets for cancer precision medicine: the ESMO Scale for Clinical Actionability of molecular Targets (ESCAT). Annals of oncology. pp. 1895-1902. [Online].